GLMD News and Press, Galmed Pharmaceuticals Ltd.

2024-06-22 09:52:47 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galmed Pharmaceuticals (NASDAQ: GLMD ) just reported results for the first quarter of 2024. Galmed Pharmaceuticals reported earnings per share of -23 cents. The compan...

2024-05-26 08:00:00 ET More on related stocks: After Doubling, A Downgrade For DICK'S Sporting Goods Is Prudent Salesforce: A Strong Buy Before Q1 Earnings Digital Turbine Q4 Earnings Preview: Potential Inflection Point Gap expected to surprise Wall Street wi...

2024-04-19 17:10:14 ET More on ContraVir Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir Read the full article on Seeking Alpha For further details see: Hepion ends Phase ...

2024-04-10 06:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now could be a great time for investors to consider stacking up on penny stocks . These companies often have significant growth potential. But they trade at low prices, typically under $5 p...

2024-04-09 10:03:48 ET More on Madrigal Pharmaceuticals Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly I...

2024-04-05 09:53:13 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galmed Pharmaceuticals (NASDAQ: GLMD ) just reported results for the fourth quarter of 2023. Galmed Pharmaceuticals reported earnings per share of -98 cents. This was belo...

Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023 PR Newswire TEL AVIV, Israel , April 4, 2024 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharm...

Sportsman's Warehouse Holdings Inc. (SPWH) is expected to report $-0.3 for Q4 2024 IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2024-01-31 Klepierre (KLPEF) is expected to report for Q4 2023 Steakholder Foods Ltd. (STKH) is expected to report for Q4 2023 R...

2024-03-18 17:45:43 ET More on Inventiva Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause Inventiva resumes Phase 3 study for NASH drug, stock up 6% Inventiva drops after adverse event in Phase 3 trial for NASH drug Seeking Alphaȁ...

2024-03-16 12:57:30 ET More on Madrigal Pharmaceuticals Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Ra...